1. MicroRNA Expression Signature in Degenerative Aortic Stenosis
- Author
-
Shi, Jing, Liu, Hui, Wang, Hui, and Kong, Xiangqing
- Subjects
Adult ,Male ,0301 basic medicine ,Article Subject ,lcsh:Medicine ,Disease ,030204 cardiovascular system & hematology ,Biology ,Bioinformatics ,General Biochemistry, Genetics and Molecular Biology ,03 medical and health sciences ,0302 clinical medicine ,microRNA ,medicine ,Humans ,KEGG ,Gene ,Regulation of gene expression ,General Immunology and Microbiology ,Microarray analysis techniques ,Gene Expression Profiling ,lcsh:R ,valvular heart disease ,Aortic Valve Stenosis ,General Medicine ,Middle Aged ,medicine.disease ,Gene expression profiling ,body regions ,MicroRNAs ,030104 developmental biology ,Gene Expression Regulation ,embryonic structures ,Female ,Research Article - Abstract
Degenerative aortic stenosis, characterized by narrowing of the exit of the left ventricle of the heart, has become the most common valvular heart disease in the elderly. The aim of this study was to investigate the microRNA (miRNA) signature in degenerative AS. Through microarray analysis, we identified the miRNA expression signature in the tissue samples from healthy individuals (n=4) and patients with degenerative AS (n=4). Six miRNAs (hsa-miR-193a-3p, hsa-miR-29b-1-5p, hsa-miR-505-5p, hsa-miR-194-5p, hsa-miR-99b-3p, and hsa-miR-200b-3p) were overexpressed and 14 (hsa-miR-3663-3p, hsa-miR-513a-5p, hsa-miR-146b-5p, hsa-miR-1972, hsa-miR-718, hsa-miR-3138, hsa-miR-21-5p, hsa-miR-630, hsa-miR-575, hsa-miR-301a-3p, hsa-miR-636, hsa-miR-34a-3p, hsa-miR-21-3p, and hsa-miR-516a-5p) were downregulated in aortic tissue from AS patients. GeneSpring 13.1 was used to identify potential human miRNA target genes by comparing a 3-way comparison of predictions from TargetScan, PITA, and microRNAorg databases. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis were performed to identify potential pathways and functional annotations associated with AS. Twenty miRNAs were significantly differentially expressed between patients with AS samples and normal controls and identified potential miRNA targets and molecular pathways associated with this morbidity. This study describes the miRNA expression signature in degenerative AS and provides an improved understanding of the molecular pathobiology of this disease.
- Published
- 2016
- Full Text
- View/download PDF